Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk
- PMID: 16735485
- DOI: 10.1210/jc.2006-0460
Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk
Abstract
Context: Fractures are a major health burden in elderly institutionalized persons. Type 2 diabetes mellitus (DM) has a high prevalence in nursing home patients and has been associated with positive effects on bone mass in younger, community-dwelling elderly.
Objective: The objective of this study was to investigate whether type 2 DM affects bone mass, bone turnover, or prospective fracture rates in frail, elderly women living in nursing homes.
Design, setting, and participants: This study was a prospective cohort of 583 patients with type 2 DM and 1081 control (CTR) individuals above age 70 recruited from 95 nursing homes in Austria. Patients were enrolled and followed up by mobile study teams.
Main outcome measures: We performed quantitative bone ultrasound measurements at the calcaneus, radius, and proximal third phalanx, measurements of quadriceps strength, and biochemical parameters of mineral metabolism and bone turnover. Patients were prospectively followed for hip and other nonvertebral fractures over 2 yr.
Results: Patients with type 2 DM had significantly higher age-, weight-, and mobility score-adjusted calcaneal stiffness (P < 0.0001), radial speed of sound (P < 0.005), and phalangeal speed of sound (P < 0.05) measurements when compared with CTRs. Mean serum PTH (-20.7%) and osteocalcin levels (-22.3%) were significantly lower (both P < 0.0001) in patients with treated type 2 DM despite comparable low serum 25-hydroxyvitamin D levels and slightly higher adjusted total serum calcium levels compared with CTRs. Important independent determinants of bone turnover in both patient groups were PTH, creatinine clearance, alanine aminotransferase, as well as glycosylated hemoglobin levels, together accounting for 30-40% of its variance. A total of 110 hip fractures occurred during the observation period, corresponding to a hip fracture rate of 3.1% (in CTRs) and 3.4% (in type 2 DM) per 100 patient years; this was not significantly different for CTRs and diabetics.
Conclusions: Decreased PTH levels and higher levels of glycemia independently contribute to lower bone turnover in elderly nursing home patients with type 2 DM. Despite higher bone mass and lower bone turnover, hip fracture risk is comparable with women without DM.
Comment in
-
Type 2 diabetes, thiazolidinediones: bad to the bone?J Clin Endocrinol Metab. 2006 Sep;91(9):3276-8. doi: 10.1210/jc.2006-1235. J Clin Endocrinol Metab. 2006. PMID: 16960122 No abstract available.
Similar articles
-
Hip and nonvertebral fracture prediction in nursing home patients: role of bone ultrasound and bone marker measurements.J Clin Endocrinol Metab. 2007 May;92(5):1678-86. doi: 10.1210/jc.2006-2079. Epub 2007 Feb 20. J Clin Endocrinol Metab. 2007. PMID: 17311861
-
Sclerostin in institutionalized elderly women: associations with quantitative bone ultrasound, bone turnover, fractures, and mortality.J Am Geriatr Soc. 2014 Jun;62(6):1023-9. doi: 10.1111/jgs.12791. Epub 2014 Apr 29. J Am Geriatr Soc. 2014. PMID: 24779429
-
Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus.Osteoporos Int. 2005 Dec;16(12):1506-12. doi: 10.1007/s00198-005-1877-5. Epub 2005 Apr 12. Osteoporos Int. 2005. PMID: 15824889
-
The impact of diabetes and diabetes medications on bone health.Endocr Rev. 2015 Apr;36(2):194-213. doi: 10.1210/er.2012-1042. Epub 2015 Mar 4. Endocr Rev. 2015. PMID: 25738213 Review.
-
Effects of Diabetes on Bone Material Properties.Curr Osteoporos Rep. 2019 Dec;17(6):455-464. doi: 10.1007/s11914-019-00538-6. Curr Osteoporos Rep. 2019. PMID: 31713179 Free PMC article. Review.
Cited by
-
Bone, sweet bone--osteoporotic fractures in diabetes mellitus.Nat Rev Endocrinol. 2012 Jan 17;8(5):297-305. doi: 10.1038/nrendo.2011.233. Nat Rev Endocrinol. 2012. PMID: 22249517 Review.
-
Circulating osteogenic precursor cells in type 2 diabetes mellitus.J Clin Endocrinol Metab. 2012 Sep;97(9):3240-50. doi: 10.1210/jc.2012-1546. Epub 2012 Jun 27. J Clin Endocrinol Metab. 2012. PMID: 22740707 Free PMC article.
-
Reduced serum osteocalcin concentrations are associated with type 2 diabetes mellitus and the metabolic syndrome components in postmenopausal women: the crosstalk between bone and energy metabolism.J Bone Miner Metab. 2012 Nov;30(6):683-91. doi: 10.1007/s00774-012-0367-z. Epub 2012 Jul 3. J Bone Miner Metab. 2012. PMID: 22752126
-
Circulating osteocalcin level is not associated with incident type 2 diabetes in middle-aged male subjects: mean 8.4-year retrospective follow-up study.Diabetes Care. 2012 Sep;35(9):1919-24. doi: 10.2337/dc11-2471. Epub 2012 Jul 6. Diabetes Care. 2012. PMID: 22773701 Free PMC article.
-
Bone metabolism and the 10-year probability of hip fracture and a major osteoporotic fracture using the country-specific FRAX algorithm in men over 50 years of age with type 2 diabetes mellitus: a case-control study.Clin Rheumatol. 2013 Aug;32(8):1161-7. doi: 10.1007/s10067-013-2254-y. Epub 2013 Apr 16. Clin Rheumatol. 2013. PMID: 23588883
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical